Philogen SpA (STU:78Q) Change In Inventory : €-1.03 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Change In Inventory?

Philogen SpA's change in inventory for the quarter that ended in Dec. 2024 was €-0.34 Mil. It means Philogen SpA's inventory increased by €0.34 Mil from Jun. 2024 to Dec. 2024 .

Philogen SpA's change in inventory for the fiscal year that ended in Dec. 2024 was €-1.03 Mil. It means Philogen SpA's inventory increased by €1.03 Mil from Dec. 2023 to Dec. 2024 .

Philogen SpA's Total Inventories for the quarter that ended in Dec. 2024 was €3.26 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Philogen SpA's Days Inventory for the quarter that ended in Dec. 2024 was 53.63.

Inventory Turnover measures how fast the company turns over its inventory within a year. Philogen SpA's Inventory Turnover for the quarter that ended in Dec. 2024 was 3.40.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Philogen SpA's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.04.

Philogen SpA Change In Inventory Historical Data

The historical data trend for Philogen SpA's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Change In Inventory Chart

Philogen SpA Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

-0.16

-0.52

-0.62

-0.32

-1.03

Philogen SpA Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Inventory	Get a 7-Day Free Trial					0.01	-0.61	0.29	-0.69	-0.34

Philogen SpA Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-1.03 Mil.

Philogen SpA (STU:78Q) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Philogen SpA's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	3.0985	/	10.545	*	365 / 2
	=	53.63

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Philogen SpA's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	10.545	/	3.0985
	=	3.40

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Philogen SpA's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	3.0985	/	73.217
	=	0.04

Philogen SpA Change In Inventory Related Terms

Thank you for viewing the detailed overview of Philogen SpA's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Philogen SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

PHIL:Italy 78Q:Germany

Address

Piazza La Lizza No. 7, Siena, ITA, 53100

Website

https://www.philogen.com

Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

No Headlines